A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a
- PMID: 18619962
- DOI: 10.1016/j.febslet.2008.06.056
A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a
Abstract
The transcription factor ecotropic viral integration site 1 (Evi1) is associated with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients due to chromosomal aberration of chromosome 3. Here we show that Evi1 interacts with the histone methyltransferase SUV39H1. The interaction requires the N-terminal part of Evi1 and the H3-specific histone methyltransferase domain, SET, of SUV39H1 without Evi1 having an inhibitory effect on SUV39H1 methyltransferase activity. Presence of SUV39H1 enhances Evi1 transcriptional repression in a dose dependent manner. In addition, Evi1 also interacts with another histone methyltransferase, G9a, but not with SET9. Our data establish an epigenetic role of Evi1 in cell transformation by recruiting higher order chromatin remodeling complexes.
Similar articles
-
EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.J Cell Biochem. 2008 Oct 1;105(2):344-52. doi: 10.1002/jcb.21869. J Cell Biochem. 2008. PMID: 18655152
-
Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.Biochemistry. 2008 Jun 17;47(24):6418-26. doi: 10.1021/bi800267f. Epub 2008 May 24. Biochemistry. 2008. PMID: 18500823
-
SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.Nature. 2007 Nov 15;450(7168):440-4. doi: 10.1038/nature06268. Nature. 2007. PMID: 18004385
-
The role of EVI1 in myeloid malignancies.Blood Cells Mol Dis. 2014 Jun-Aug;53(1-2):67-76. doi: 10.1016/j.bcmd.2014.01.002. Epub 2014 Feb 1. Blood Cells Mol Dis. 2014. PMID: 24495476 Review.
-
EVI1 and hematopoietic disorders: history and perspectives.Gene. 2006 Mar 1;368:1-11. doi: 10.1016/j.gene.2005.09.020. Epub 2005 Nov 28. Gene. 2006. PMID: 16314052 Review.
Cited by
-
Gene therapy activates EVI1, destabilizes chromosomes.Nat Med. 2010 Feb;16(2):163-5. doi: 10.1038/nm0210-163. Nat Med. 2010. PMID: 20134468 No abstract available.
-
Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.J Korean Med Sci. 2013 Feb;28(2):237-46. doi: 10.3346/jkms.2013.28.2.237. Epub 2013 Jan 29. J Korean Med Sci. 2013. PMID: 23400519 Free PMC article.
-
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.Nat Med. 2010 Feb;16(2):198-204. doi: 10.1038/nm.2088. Epub 2010 Jan 24. Nat Med. 2010. PMID: 20098431
-
Phosphorylation of SU(VAR)3-9 by the chromosomal kinase JIL-1.PLoS One. 2010 Apr 6;5(4):e10042. doi: 10.1371/journal.pone.0010042. PLoS One. 2010. PMID: 20386606 Free PMC article.
-
Evi-1 as a critical regulator of leukemic cells.Int J Hematol. 2010 Jun;91(5):753-7. doi: 10.1007/s12185-010-0618-5. Epub 2010 Jun 8. Int J Hematol. 2010. PMID: 20532840 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous